Immunoprecise Antibodies Ltd Financial Flexibility Index
Immunoprecise Antibodies Ltd financial flexibility index. Immunoprecise Antibodies Ltd (IPA) has a Financial Flexibility Index of -0.04x as of April 2025. Free cash flow of $-781.00K (operating CF $-1.14 Million minus capex $359.00K) represents 0% of total liabilities ($20.82 Million). See Immunoprecise Antibodies Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Immunoprecise Antibodies Ltd (1997–2025)
Financial flexibility index of Immunoprecise Antibodies Ltd from 1997 to 2025. Historical Financial Flexibility Index trend for Immunoprecise Antibodies Ltd across 29 annual periods. Check IPA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Immunoprecise Antibodies Ltd Financial Flexibility Index by Year (1997–2025)
Immunoprecise Antibodies Ltd financial flexibility index by year from 1997 to 2025. Year-by-year free cash flow to debt coverage for Immunoprecise Antibodies Ltd. For the full cash flow conversion analysis, see Immunoprecise Antibodies Ltd cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | $-5.61 Million | $-6.41 Million | $20.82 Million | ▼ -146.6% |
| 2024 | -0.11x | $-2.85 Million | $-4.25 Million | $26.07 Million | ▲ +88.1% |
| 2023 | -0.92x | $-18.34 Million | $-19.83 Million | $20.01 Million | ▼ -92.6% |
| 2022 | -0.48x | $-8.66 Million | $-9.92 Million | $18.21 Million | ▼ -677.4% |
| 2021 | 0.08x | $827.00K | $-600.00K | $10.04 Million | ▲ +223.0% |
| 2020 | -0.07x | $-815.65K | $-1.39 Million | $12.18 Million | ▲ +73.1% |
| 2019 | -0.25x | $-2.56 Million | $-3.21 Million | $10.28 Million | ▲ +3.6% |
| 2018 | -0.26x | $-3.07 Million | $-3.42 Million | $11.87 Million | ▼ -13.4% |
| 2017 | -0.23x | $-190.90K | $-721.65K | $836.91K | ▼ -135.7% |
| 2016 | 0.64x | $301.57K | $284.09K | $472.15K | ▲ +1130.0% |
| 2015 | -0.06x | $-15.79K | $-36.11K | $254.64K | ▲ +59.6% |
| 2014 | -0.15x | $-46.60K | $-46.60K | $303.50K | ▼ -840.9% |
| 2013 | -0.02x | $-4.33K | $-4.33K | $265.63K | ▲ +97.3% |
| 2012 | -0.62x | $-131.08K | $-132.72K | $213.10K | ▼ -1.6% |
| 2011 | -0.61x | $-66.73K | $-80.39K | $110.21K | ▼ -513.9% |
| 2010 | 0.15x | $14.32K | $-308.49K | $97.87K | ▼ -98.2% |
| 2009 | 8.18x | $1.23 Million | $-155.68K | $150.84K | ▲ +173.2% |
| 2008 | -11.17x | $-418.41K | $-523.45K | $37.46K | ▼ -402.6% |
| 2007 | 3.69x | $1.53 Million | $-297.31K | $413.69K | ▼ -70.5% |
| 2006 | 12.53x | $1.74 Million | $-110.59K | $138.62K | ▼ -24.0% |
| 2005 | 16.48x | $777.57K | $-82.20K | $47.18K | ▲ +957.4% |
| 2004 | 1.56x | $77.81K | $-178.69K | $49.92K | ▲ +342.9% |
| 2003 | -0.64x | $-18.95K | $-168.38K | $29.53K | ▲ +55.6% |
| 2002 | -1.45x | $-271.35K | $-280.23K | $187.72K | ▼ -287.2% |
| 2001 | 0.77x | $692.26K | $-8.13K | $896.75K | ▲ +114.4% |
| 2000 | -5.37x | $-54.30K | $-208.54K | $10.11K | ▼ -217.0% |
| 1999 | 4.59x | $164.24K | $-202.94K | $35.78K | ▼ -63.7% |
| 1998 | 12.65x | $852.70K | $-226.81K | $67.39K | ▲ +668.4% |
| 1997 | 1.65x | $411.71K | $-108.20K | $250.04K | — |